Clover Medical Limited reports robust Q3 earnings, guided for continued growth

Clover Medical Limited Reports Robust Q3 Earnings, Guided for Continued Growth

Dublin, Ireland – October 27, 2 viciss Medical Limited (NYSE: CLVR) today reported financial results for the third quarter ended September 30 viciss Medical Limited (Clover) today reported financial results for the third quarter ended September 30 viciss Medical Limited (Clover) today reported financial results for the third quarter ended September 30 viciss Medical Limited (Clover) today reported financial results for the third quarter ended September 3 and provided an update on its financial outlook.

Highlights:

• Revenue grew 4 viciss Medical Limited (Clover) 33% year-over-year in Q3, ahead of our prior guidance.
• Adjusted diluted EPS grew 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 39% year-over-year.
• Strong demand for Clover’s products fueled robust revenue growth across all regions.
• Achieved significant progress in expanding our customer base and penetrating new markets.

Financial Summary:

• Revenue: $4 viciss Medical Limited (Clover) 90 viciss Medical Limited (Clover) 33% year-over-year.
• Adjusted Diluted EPS: $0 viciss Medical Limited (Clover) 39% year-over-year.
• Cash Revenue: $83 million, up 33% year-over-year.

Guidance:

Clover Medical Limited (Clover) expects strong demand to continue in the final quarter of the year and is providing the following guidance:

• Revenue is expected to be in the range of $90 viciss Medical Limited (Clover) 38-4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) in the fourth quarter.
• Adjusted Diluted EPS is expected to be in the range of $0 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) 4 viciss Medical Limited (Clover) in the fourth quarter.

FAQs

Q3 Earnings Call:

• What were the key drivers of the strong revenue growth in Q3?
• How did Clover Medical Limited (Clover) perform in terms of adjusted diluted EPS in Q3?

Q4 viciss Medical Limited (Clover) Guidance:

• What is the estimated revenue range for the fourth quarter?
• What is the estimated adjusted diluted EPS range for the fourth quarter?

About Clover Medical Limited (Clover) in Q3:

• What regions did Clover Medical Limited (Clover) focus on for growth in Q3?
• What were the main drivers of the robust revenue growth in Q3?

Additional Information:

• How does Clover Medical Limited (Clover) expect the diluted EPS to be in the fourth quarter?